ArticleInternal medicine (Tokyo, Japan)2020

Serum Endocrine Fibroblast Growth Factors as Potential Biomarkers for Chronic Kidney Disease and Various Metabolic Dysfunctions in Aged Patients.

Shogo Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.